This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

How Apple's iPhone Ad Hints at Its Next Big Thing

Walkley noted that Healthkit (part of the Health app) is important because it has "deals with hospitals such as the Mayo Clinic to enable better monitoring of health, incorporating wearable devices." As part of the announcement, Apple announced that Health (with users permissions), can integrate doctors to see how the user is doing. The company has an enormous list of hospitals and clinics it's working with, including Johns Hopkins, Yale, Stanford, Mount Sinai and many, many others. 

Walkley rates Apple shares "buy" with a $710 price target.

Though the health and fitness app market is expected to reach $24 billion by the end of 2017, the hardware market for wearable technology is even more promising, allowing Apple to hit this burgeoning trend on both fronts. This market is expected to be worth $60 billion by 2018, according to research firm IHS.

Cantor Fitzgerald analyst Brian White, who rates Apple shares "buy" with a $777 price target, notes HealthKit may be a precursor to the iWatch.

"In our view, HealthKit is very interesting and dovetails with our expectation of an "iWatch" launch this fall, which we believe can take advantage of health-related monitoring," White said in a research note. "Apple highlighted working with Nike and the Mayo Clinic as it relates to HealthKit."

Apple does approximately $170 billion a year in revenue, and the iWatch, though it would not be as large a revenue driver as the iPhone, it may wind up being noteworthy, especially at it grows over time. "Our working assumption is that iWatch will largely be adopted as an accessory device and therefore sold into the existing customer base like the iPad rather than to new customers like the iPod or iPhone," Morgan Stanley analyst Katy Huberty wrote in Feb. research note about Apple. "Assuming an ASP of $299 and Apple customer base penetration rate similar to the iPad, we see up to $17.5B of revenue in the first 12 months compared to $12B for the iPad and $2.5B for the iPhone."

As speculation about Apple's move into the health market as its next big thing has increased, the company's stock price has rose, buoyed by strong fiscal second-quarter earnings, and shareholder friendly moves, including an increase to the buyback and dividend program, as well as a 7-for-1 stock split.

Apple reported second-quarter earnings of $11.62 a share, generating $45.6 billion in revenue. The company shipped 43.7 million iPhones, 16.4 million iPads, and shipped 4.1 million Macs during the quarter. Gross margin, a highly watched level for Apple, came in at 39.3%. Apple also announced that it was upping its capital allocation program to over $130 billion by the end of calendar year 2015. As part of the program, the board increased its share repurchase authorization to $90 billion from $60 billion, and boosted its quarterly dividend by 8%, to $3.29 a share. The stock split is effective June 2 and shares will begin trading on a split-adjusted basis on June 9.

Though the iPhone ad may be focusing on what users can do with the iconic smartphone, it speaks to a broader trend. The company is saying consumers are ready for wearable technology -- and it's coming, sooner rather than later.


Also See: Apple WWDC Live Blog Recap

Also See: Apple WWDC: What Wall Street's Saying

Also See: How Apple's iWatch Can Help Wearables

--Written by Chris Ciaccia in New York

>Contact by Email.

2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,055.87 -116.81 -0.68%
S&P 500 1,982.77 -11.52 -0.58%
NASDAQ 4,508.6880 -19.0010 -0.42%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs